Crystal Peak Investment Inc. - 04 Feb 2026 SCHEDULE 13D/A Report for LakeShore Biopharma Co., Ltd Ordinary Shares, par value $0.0002 per share (LSBCF)

Filing Manager
Crystal Peak Investment Inc.
Reporting Manager
Crystal Peak Investment Inc.
Security
LakeShore Biopharma Co., Ltd Ordinary Shares, par value $0.0002 per share
Symbol
LSBCF
Shares outstanding
41,218,298 shares
Disclosed Ownership
21,021,332 shares
Ownership
51%
Form type
SCHEDULE 13D/A
Filing time
05 Feb 2026, 07:42:02 UTC
Date of event
04 Feb 2026
Previous filing
04 Nov 2025
SEC
View on sec.gov

Reporting Managers (15)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Huaqin Xue 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue
Crystal Peak Holdings Inc. 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue/Director
Crystal Peak Investment Inc. 51% 21,021,332 21,021,332 0 /s/ Huaqin Xue Huaqin Xue/Director 0002078050
Dave Liguang Chenn 1.1% 462,760 462,760 0 /s/ Dave Liguang Chenn Dave Liguang Chenn
Oceanpine Investment Fund II LP 1% 410,560 410,560 0 /s/ Dave Liguang Chenn Dave Liguang Chenn/Director
Oceanpine Capital Inc. 0.1% 52,200 52,200 0 /s/ Jiayu Yang Jiayu Yang/Director
Adjuvant Capital Management, L.L.C. 0.7% 290,298 0 290,298 /s/ Kabeer Aziz Kabeer Aziz/Vice President & Secretary
Adjuvant Capital GP, L.P. 0.7% 290,298 0 290,298 /s/ Kabeer Aziz Kabeer Aziz/Vice President & Secretary
Adjuvant Global Health Technology Fund, L.P. 0.59% 243,630 0 243,630 /s/ Kabeer Aziz Kabeer Aziz/Vice President & Secretary
Adjuvant Global Health Technology Fund DE, L.P. 0.11% 46,668 0 46,668 /s/ Kabeer Aziz Kabeer Aziz/Vice President & Secretary
MSA China Growth Fund II GP, LLC 0.27% 112,904 112,904 0 /s/ Yu (Jenny) Zeng Yu (Jenny) Zeng/Manager
MSA Growth Fund II, L.P. 0.27% 112,904 112,904 0 /s/ Yu (Jenny) Zeng Yu (Jenny) Zeng/Managing Partner
Superstring Capital Management LP 0.07% 30,792 30,792 0 /s/ Ting Guo Ting Guo/Managing Partner
Superstring Capital Master Fund LP 0.07% 30,792 30,792 0 /s/ Ting Guo Ting Guo/General Partner
Epiphron Capital (Hong Kong) Limited 0.17% 70,083 70,083 0 /s/ Sherry Xiaoyu Liu Sherry Xiaoyu Liu/Director